MELANOMA BRIDGE
November 30th - December 2nd, 2023
PRESIDENTS
Paolo A. Ascierto
Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Corrado Caracò
Director of Melanoma and Skin Tumor Surgery, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Iman Osman
Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, NYU Grossman School of Medicine, New York, NY, US
Igor Puzanov
Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US
SCIENTIFIC BOARD
Sanjiv S. Agarwala
Professor of Hematology & Oncology, Temple University School of Medicine, Philadelphia, PA, US
Paolo A. Ascierto
Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Carlo Bifulco
Medical Director of Oncological Molecular Pathology and Pathology Informatics, Providence Oregon Regional Laboratory; Director, Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US
Elizabeth M. Burton
Director, Research Planning & Development, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, US
Lisa H. Butterfield
Adjunct Professor, Microbiology and Immunology, University of California San Francisco; Vice President, PICI Research Center/ PICI Research & Development, San Francisco, CA, US
Corrado Caracò
Director of Melanoma and Skin Tumor Surgery, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Mary Dean
Executive Director, Society for Immunotherapy of Cancer (SITC), Milwaukee, WI, US
Sandra Demaria
Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology, Weill Cornell Medical College, New York, NY, US
Reinhard Dummer
Vice Director, Department of Dermatology; Director, Clinical Trials Comprehensive Cancer Center Zurich (CCCZ), University Hospital Zurich, Zurich, Switzerland
Alexander M.M. Eggermont
Chief Scientific Officer, Board of Directors, Princess Máxima Center; Professor of Clinical&Translational Immunotherapy, Utrecht University, Utrecht, Netherlands
Leisha A. Emens
Professor of Medicine, Director of Translational Immunotherapy for the Women’s Cancer Research Center, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, UPMC Hillman Cancer Center/Magee Women’s Hospital, Pittsburgh, PA, US
Bernard A. Fox
Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US
Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Director, Integrative Cancer Immunology Team, Cordeliers Research Center, Paris, France
Claus Garbe
Professor of Dermatology, President of the European Association of DermatoOncology (EADO), Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany
Jeffrey E. Gershenwald
Professor of Cancer Biology, Departments of Surgical Oncology and Cancer Biology, Medical Director, Melanoma and Skin Center, The University of Texas, MD Anderson Cancer Center, Houston, TX, US
Omid Hamid
Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US
Patrick Hwu
President & CEO, Moffitt Cancer Center, Tampa, FL, US
Giuseppe Masucci
Associate Professor, Department of Oncology-Pathology and KcRN, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden
Olivier Michielin
Full Professor, Chair of Precision Oncology Center, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland
Iman Osman
Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, NYU Grossman School of Medicine, New York, NY, US
Giuseppe Palmieri
Full Professor of Medical Oncology, University of Sassari; Immuno-Oncology & Targeted Cancer Biotherapies, Sassari University Hospital; Associate Researcher, Head of Unit of Cancer Genetics, National Research Council (CNR); Head, Institute of Genetic & Biomedical Research (IRGB), Sassari, Italy
Michael A. Postow
Chief, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US
Igor Puzanov
Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US
Tara Withington
Executive Director Emeritus, Society for Immunotherapy of Cancer (SITC), Milwaukee, WI, US
